Inhibition of sodium/hydrogen exchanger 3 in the gastrointestinal tract by tenapanor reduces paracellular phosphate permeability

Journal: Science Translational Medicine

Published: 2018-08-29

DOI: 10.1126/scitranslmed.aam6474

Affiliations: 8

Authors: 31

Go to article
Institutions FC
Ardelyx, Inc., United States of America (USA) 0.52
AstraZeneca-Max Planck Launch Cardiovascular and Metabolic Disease (CVMD) Collaboration, Sweden 0.19
NCCR Kidney.CH - Kidney Control of Homeostasis, Switzerland 0.13
University of Alberta (U of A), Canada 0.10
UCL Department of Neuroscience, Physiology and Pharmacology (NPP), United Kingdom (UK) 0.03
Johns Hopkins University School of Medicine (JHUSOM), JHU, United States of America (USA) 0.03